195 related articles for article (PubMed ID: 8542203)
1. Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome.
McNally T; Mackie IJ; Machin SJ; Isenberg DA
Br J Rheumatol; 1995 Nov; 34(11):1031-6. PubMed ID: 8542203
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
3. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
Teixidó M; Font J; Reverter JC; Cervera R; Tàssies D; Ingelmo M; Escolar G; Ordinas A
Br J Rheumatol; 1997 Jan; 36(1):113-6. PubMed ID: 9117149
[TBL] [Abstract][Full Text] [Related]
4. Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis.
Martinuzzo ME; Forastiero RR; Carreras LO
Br J Haematol; 1995 Feb; 89(2):397-402. PubMed ID: 7873391
[TBL] [Abstract][Full Text] [Related]
5. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against phospholipids and beta 2-glycoprotein I increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus.
Wahl DG; De Maistre E; Guillemin F; Regnault V; Perret-Guillaume C; Lecompte T
QJM; 1998 Feb; 91(2):125-30. PubMed ID: 9578894
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
8. [Anti-beta 2-glycoprotein I antibodies and systemic lupus erythematosus].
Antolín J; Almeida D; Amérigo MJ; Cantabrana A; Roces A; Hayeck M
Med Clin (Barc); 2002 Sep; 119(9):331-2. PubMed ID: 12356362
[TBL] [Abstract][Full Text] [Related]
9. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.
Roubey RA; Pratt CW; Buyon JP; Winfield JB
J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to endothelial cells and to beta 2-glycoprotein I in the antiphospholipid syndrome: prevalence and isotype distribution.
Navarro M; Cervera R; Teixidó M; Reverter JC; Font J; López-Soto A; Monteagudo J; Escolar G; Ingelmo M
Br J Rheumatol; 1996 Jun; 35(6):523-8. PubMed ID: 8670571
[TBL] [Abstract][Full Text] [Related]
11. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus.
Tsutsumi A; Matsuura E; Ichikawa K; Fujisaku A; Mukai M; Kobayashi S; Koike T
Arthritis Rheum; 1996 Sep; 39(9):1466-74. PubMed ID: 8814057
[TBL] [Abstract][Full Text] [Related]
13. Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship with antibodies to beta2-glycoprotein I.
González C; Lestón A; García-Berrocal B; Sánchez-Rodriguez A; Martín-Oterino JA; Alberca I; Cordero M; Jorge R; Navajo JA; González-Buitrago JM
J Clin Lab Anal; 1999; 13(2):59-64. PubMed ID: 10102133
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
15. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Samarkos M; Davies KA; Gordon C; Loizou S
Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
19. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
Arvieux J; Darnige L; Hachulla E; Roussel B; Bensa JC; Colomb MG
Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
[TBL] [Abstract][Full Text] [Related]
20. [Anti-beta 2 glycoprotein I antibodies. Relationship with antiphospholipid antibodies and thrombosis].
Ordi Ros J; Falgà Tirado C; Monegal Ferran F; Selva O'Callaghan A; Pérez Pemán P; Cucurull E; Vilardell Tarres M
Med Clin (Barc); 1995 Feb; 104(7):245-8. PubMed ID: 7731286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
